Exploiting genetic alterations to design novel therapies for cancer

T P Cripe1, C L Mackall

  • 1Department of Pediatrics, Division of Hematology/Oncology, Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, USA. t.cripe@chmcc.org

Insights

Cancer research has uncovered key genetic changes driving tumor growth. New therapies like gene therapy, viral therapy, and immunotherapy are being developed to target these specific molecular alterations for improved cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Significant advancements in understanding cancer's molecular basis over the past 30 years.
  • Molecular genetic studies have identified critical genetic rearrangements, like chromosomal translocations, in various cancers.
  • Progress in diagnostics and prognostics has outpaced the development of targeted therapeutic strategies.

Purpose of the Study:

  • To review emerging therapeutic strategies that leverage cancer-specific genetic alterations.
  • To explore the potential of gene therapy, viral therapy, and immunotherapy in cancer treatment.
  • To inform healthcare professionals about novel treatment modalities for cancer patients.

Main Methods:

  • Review of current research and development in cancer gene therapy.
  • Analysis of viral therapy approaches targeting cancer genetics.
  • Examination of immunotherapy strategies based on molecular cancer profiles.

Main Results:

  • Identification of diverse methods to exploit genetic changes for targeted cancer therapy.
  • Development of novel anticancer agents based on gene therapy, viral therapy, and immunotherapy.
  • These approaches show promise for more specific and effective cancer treatments.

Conclusions:

  • Exploiting cancer's genetic vulnerabilities offers promising new therapeutic avenues.
  • Gene therapy, viral therapy, and immunotherapy represent key areas of development.
  • Healthcare professionals must stay informed about these evolving treatment options to guide patients effectively.

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...